Unlocking Q1 Potential of Synopsys (SNPS): Exploring Wall Street Estimates for Key Metrics

21.02.25 15:15 Uhr

Werte in diesem Artikel
Aktien

410,05 EUR -1,85 EUR -0,45%

Indizes

19.754,0 PKT 76,4 PKT 0,39%

17.784,1 PKT 92,4 PKT 0,52%

5.667,6 PKT 4,7 PKT 0,08%

In its upcoming report, Synopsys (SNPS) is predicted by Wall Street analysts to post quarterly earnings of $2.81 per share, reflecting a decline of 21.1% compared to the same period last year. Revenues are forecasted to be $1.45 billion, representing a year-over-year decrease of 11.9%.Over the past 30 days, the consensus EPS estimate for the quarter has remained unchanged. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.With that in mind, let's delve into the average projections of some Synopsys metrics that are commonly tracked and projected by analysts on Wall Street.The consensus estimate for 'Revenue- Maintenance and service' stands at $265.57 million. The estimate suggests a change of -10.6% year over year.Analysts' assessment points toward 'Revenue- Total products revenue' reaching $1.19 billion. The estimate indicates a change of -12.2% from the prior-year quarter.The consensus among analysts is that 'Revenue by segment- Design IP' will reach $425.91 million. The estimate suggests a change of -19% year over year.According to the collective judgment of analysts, 'Revenue by segment- Design Automation' should come in at $1.02 billion. The estimate indicates a change of +4% from the prior-year quarter.Analysts predict that the 'Revenue- Upfront products' will reach $393.08 million. The estimate suggests a change of -12.2% year over year.The collective assessment of analysts points to an estimated 'Revenue- Time-based products' of $783.55 million. The estimate indicates a year-over-year change of -13.4%.View all Key Company Metrics for Synopsys here>>>Shares of Synopsys have demonstrated returns of -10.4% over the past month compared to the Zacks S&P 500 composite's +2.2% change. With a Zacks Rank #3 (Hold), SNPS is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>7 Best Stocks for the Next 30 DaysJust released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."Since 1988, the full list has beaten the market more than 2X over with an average gain of +24.3% per year. So be sure to give these hand picked 7 your immediate attention. See them now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Synopsys, Inc. (SNPS): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Synopsys und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf Synopsys

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Synopsys

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Synopsys Inc.

Wer­bung

Analysen zu Synopsys Inc.

DatumRatingAnalyst
22.08.2019Synopsys BuyNeedham & Company, LLC
03.04.2019Synopsys BuyNeedham & Company, LLC
28.03.2019Synopsys BuyNeedham & Company, LLC
06.12.2018Synopsys BuyNeedham & Company, LLC
06.12.2018Synopsys BuyThe Benchmark Company
DatumRatingAnalyst
22.08.2019Synopsys BuyNeedham & Company, LLC
03.04.2019Synopsys BuyNeedham & Company, LLC
28.03.2019Synopsys BuyNeedham & Company, LLC
06.12.2018Synopsys BuyNeedham & Company, LLC
06.12.2018Synopsys BuyThe Benchmark Company
DatumRatingAnalyst
09.09.2015Synopsys HoldThe Benchmark Company
04.12.2008Synopsys UpgradeCitigroup Corp.
02.02.2007Synopsys neutralDA Davidson
31.01.2007Update Synopsys Inc.: NeutralDA Davidson
30.11.2006Synopsys holdDeutsche Securities
DatumRatingAnalyst
21.08.2008Synopsys DowngradeCitigroup Corp.
24.06.2005Synopsys underweightPrudential Financial

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Synopsys Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen